ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

4-[3-(2-クロロベンゾイル)-2-ピリジル]-5-(4-ピリジル)-1-[3,5-ビス(トリフルオロメチル)ベンジル]-1H-1,2,3-トリアゾール

Tradipitant

HCID 9916461
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
622370-35-8
標準SMILES
O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1
InChIKey
CAVRKWRKTNINFF-UHFFFAOYSA-N
分子式
C28H16ClF6N5O
平均分子量
587.9 g/mol
単同位体質量
587.0947568

概要

Tradipitant is a selective, high-affinity antagonist at human substance P/neurokinin-1 (NK-1) receptors. NK-1 receptors are expressed in the brainstem and nucleus tractus solitarius, which receives emetogenic signals from various stimuli including dizziness and vertigo. Approved by the FDA on December 30, 2025, tradipitant is indicated for the prevention of vomiting induced by motion. Tradipitant has also been investigated in gastroparesis,COVID-19-induced pneumonia, and atopic dermatitis.

名称と識別子

優先名称
Tradipitant
IUPAC
[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]-3-pyridinyl]-(2-chlorophenyl)methanone
現地名
4-[3-(2-クロロベンゾイル)-2-ピリジル]-5-(4-ピリジル)-1-[3,5-ビス(トリフルオロメチル)ベンジル]-1H-1,2,3-トリアゾール
英語名
Tradipitant
分子式
C28H16ClF6N5O
分子量
587.9

名称と別名

Tradipitant622370-35-8LY686017LY-686017VLY-686NY0COC51FI[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]pyridin-3-yl]-(2-chlorophenyl)methanoneDTXSID801045805Methanone, (2-(1-((3,5-bis(trifluoromethyl)phenyl)methyl)-5-(4-pyridinyl)-1H-1,2,3-triazol-4-yl)-3-pyridinyl)(2-chlorophenyl)-tradipitantum(2-(1-((3,5-bis(trifluoromethyl)phenyl)methyl)-5-pyridin-4-yltriazol-4-yl)pyridin-3-yl)-(2-chlorophenyl)methanoneMethanone, [2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-(4-pyridinyl)-1H-1,2,3-triazol-4-yl]-3-pyridinyl](2-chlorophenyl)-
名称をさらに表示
2-(1-{[3,5-ビス(トリフルオロメチル)フェニル]メチル}-5-(ピリジン-4-イル)-1H-1,2,3-トリアゾール-4-イル)-3-(2-クロロベンゾイル)ピリジン4-[3-(2-クロロベンゾイル)-2-ピリジル]-5-(4-ピリジル)-1-[3,5-ビス(トリフルオロメチル)ベンジル]-1H-1,2,3-トリアゾールトラジピタント(2-bromopyridin-3-yl)(2-chlorophenyl)methanoneVLY 686BiafunginTradipitant APITradipitant(VLY-686)Tradipitant, 10 mM in DMSOtradipitant,VLY-686, LY686017
RefChem:933246DTXCID6015277342-(1-((3,5-bis(trifluoromethyl)phenyl)methyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)-3-(2-chlorobenzoyl)pyridine(2-(1-(3,5-bis(trifluoromethyl)benzyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)pyridin-3-yl)(2-chlorophenyl)methanoneMFCD28127604[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-(4-pyridinyl)-1H-1,2,3-triazol-4-yl]-3-pyridinyl](2-chlorophenyl)MethanoneVLY686UNII-NY0COC51FI

物性

構造計算による物性

XLogP
6.2
極性表面積
73.6 Ų
水素結合供与体数
0
水素結合受容体数
11
回転可能結合数
6
重原子数
41
形式電荷
0
複雑度
865

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Antiemetics; Neurokinin-1 Receptor Antagonists

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

物理化学的性質

融点
143 · 143 - 145°C
沸点
640.9 · 640.9±65.0 °C(Predicted)
比重(密度)
1.45 · 1.45±0.1 g/cm3(Predicted)
貯蔵温度
-20 °C · Hygroscopic, -20°C Freezer, Under inert atmosphere
溶解性
クロロホルム(微量)、酢酸エチル(微量)
外見
個体
酸解離定数(Pka)
2.92 · 2.92±0.10(Predicted)
色
ペールベージュからブラウン
InChIKey
CAVRKWRKTNINFF-UHFFFAOYSA-N
SMILES
C(C1=CC=CN=C1C1=C(C2C=CN=CC=2)N(CC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)N=N1)(C1=CC=CC=C1Cl)=O

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

毒性情報

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

注意喚起語
警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H302

化学と産業

薬理情報

Protein BindingTradipitant plasma protein binding ranged from 96% to >99% in vitro.
Pharmacodynamics · 1 件

Tradipitant inhibits the NK-1 receptor with a Ki of 0.062 nM and effectively blocks Substance P-induced intracellular calcium mobilization. The drug crosses the blood-brain barrier and achieves high receptor occupancy; a clinical study demonstrated that tradipitant occupies approximately 93% of NK-1 receptors in the frontal cortex following multiple doses. In clinical trials involving preventing vomiting induced by motion, single oral doses of 85 mg and 170 mg demonstrated significant efficacy in reducing vomiting incidence compared to placebo, with effects observed in variable sea conditions. At the maximum recommended single dose of 170 mg, tradipitant does not cause clinically significant prolongation of the QTc interval.

Mechanism of Action · 1 件

Tradipitant is a selective, high-affinity antagonist of the human substance P/neurokinin-1 (NK-1) receptor. NK-1 receptors are widely distributed in the central nervous system, particularly in brainstem nuclei such as the nucleus tractus solitarius (NTS) and the area postrema, which play a critical role in the regulation of vomiting, as well as in the peripheral gastrointestinal tract. Tradipitant works by blocking the binding of Substance P, the endogenous ligand, to NK-1 receptors, thereby inhibiting the transmission of emetogenic sensory signals from vestibular and visceral sources to the vomiting center. Unlike some other anti-emetics, tradipitant does not exhibit affinity for serotonin (5-HT3), dopamine (D2), cholinergic, or histamine (H1) receptors.

Biological Half-LifeThe observed mean elimination half-life for tradipitant is approximately 34 hours.
Metabolism/Metabolites · 1 件

Tradipitant is extensively metabolized; however, the metabolic pathways have not been fully characterized. In vitro findings suggest that non-CYP450-mediated processes and CYP enzymes (CYP3A4, CYP2C19, and to a lesser extent by CYP2C8) are involved in the metabolism of tradipitant. Tradipitant is also glucuronidated by UGT1A4 and UGT2B7. Four major metabolites (M2, M3, M4, and M8) were identified in plasma. Following a single dose of 85 mg tradipitant in healthy subjects under fasting conditions, the AUCs of M2, M3, M4, and M8 represent 40%, 33%, 43%, and 42% of the parent AUC, respectively. The major metabolites of tradipitant (M2, M3, M4, and M8) exhibited NK-1 receptor binding affinities comparable to those of the parent drug.

関連反応

7 件
反応記録を作成
HRID 130680 の反応式
HRID 130680生成物として
HRID 130681 の反応式
HRID 130681生成物として
HRID 1620793 の反応式
HRID 1620793生成物として
HRID 2251994 の反応式
HRID 2251994反応物として
HRID 2251999 の反応式
HRID 2251999生成物として
HRID 2325569 の反応式
HRID 2325569反応物として
HRID 2336080 の反応式
HRID 2336080生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
622370-35-8
PubChem CID
9916461
DTXSID
DTXSID801045805
ChEMBL
CHEMBL3544984
UNII
NY0COC51FI
Nikkaji
J3.048.437A
Absorption, Distribution and Excretion · 4 件

Absolute oral bioavailability has not been studied in humans. Following a single dose of 85 mg tradipitant in healthy subjects under fasting conditions, tradipitant geometric mean Cmax was 84.7 ng/mL, AUC0-inf was 1839 ng x h/mL, and the median Tmax was 2.0 hours. Following a single dose of 170 mg tradipitant in healthy subjects under fasting conditions, tradipitant geometric mean Cmax was 112 ng/mL, AUC0-inf was 3,526 ng x h/mL, and the median Tmax was 1.50 hours. In healthy subjects, a high-fat meal increased AUC0-inf and Cmax, while delaying Tmax.

Following a single oral dose of radiolabeled tradipitant 25 mg, approximately 88% of the dose was recovered, with 80% of the dose in feces and 7% in urine. Unchanged tradipitant was minimal in feces and was not detected in urine.

The apparent volume of distribution (Vd/F) of tradipitant is 1956 L in healthy subjects.

The apparent oral clearance of tradipitant is 41.7 L/hour in healthy subjects.

応用分野

使用Tradipitant, is a neurokinin-1 (NK-1) antagonist.